48,830
edits
Difference between revisions of "Neuroendocrine tumour of the pancreas"
Jump to navigation
Jump to search
Neuroendocrine tumour of the pancreas (view source)
Revision as of 20:35, 5 March 2014
, 20:35, 5 March 2014→IHC
(→IHC) |
|||
| Line 88: | Line 88: | ||
==IHC== | ==IHC== | ||
*CK19 +ve -- should be done as a routine in pancreatic NETs; poor prognostic factor.<ref name=pmid19956064>{{Cite journal | last1 = Jain | first1 = R. | last2 = Fischer | first2 = S. | last3 = Serra | first3 = S. | last4 = Chetty | first4 = R. | title = The use of Cytokeratin 19 (CK19) immunohistochemistry in lesions of the pancreas, gastrointestinal tract, and liver. | journal = Appl Immunohistochem Mol Morphol | volume = 18 | issue = 1 | pages = 9-15 | month = Jan | year = 2010 | doi = 10.1097/PAI.0b013e3181ad36ea | PMID = 19956064 }}</ref> | *CK19 +ve -- should be done as a routine in pancreatic NETs; poor prognostic factor.<ref name=pmid19956064>{{Cite journal | last1 = Jain | first1 = R. | last2 = Fischer | first2 = S. | last3 = Serra | first3 = S. | last4 = Chetty | first4 = R. | title = The use of Cytokeratin 19 (CK19) immunohistochemistry in lesions of the pancreas, gastrointestinal tract, and liver. | journal = Appl Immunohistochem Mol Morphol | volume = 18 | issue = 1 | pages = 9-15 | month = Jan | year = 2010 | doi = 10.1097/PAI.0b013e3181ad36ea | PMID = 19956064 }}</ref> | ||
*Chromogranin +ve. | |||
*Synaptophysin +ve. | |||
*CD56 +ve. | |||
A panel: | |||
*Chromogranin, synaptophysin, CD10, PR, beta-catenin, CK7, pankeratin, Ki-67, CK19. | |||
Note: | Note: | ||
*''CK19'' should '''not''' be confused with ''CA19-9''. | *''CK19'' should '''not''' be confused with ''CA19-9''. | ||
==Sign out== | ==Sign out== | ||